Skip to main content
 This program is not active.
Not Found
On Demand

Pandemics: What's Past is Prologue

Total Credits: 1.0 including 1.0 AMA PRA Category 1

Duration:
:59
Format:
Audio and Video

Description

Pandemics: What's Past is Prologue
David Engelthaler, PhD, MS

Learning Objectives

  • Differentiate the parallels and differences between the Spanish Flu Pandemic and COVID-19
  • Convey the impact 21st Century science and Technology has made on modern day pandemics like COVID-19
  • Share what we have learned from old pandemics that can be applied today

Faculty and Planning Committee Disclosures
The following faculty and/or planning committee members have indicated that they may have a relevant financial relationship with an ineligible company that could be perceived as a potential conflict of interest.

Faculty
Dr. Engelthaler has no disclosures.

Planning Committee
Dr. David Leff discloses he is on the Speakers' Bureau for Abbvie, Alfa Sigma, Allergan, Gilead and Salix.

All relevant financial relationships have been mitigated.

All other faculty and planning committee members have no relevant financial relationships with ineligible companies.

Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the American Osteopathic Association (AOA) and Accreditation Council for Continuing Medical Education (ACCME) Guidelines and Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 1951 W Camelback Rd, Suite 105, Phoenix, AZ 85015 or by email to info@azosteo.org.

 

 

Faculty

David Engelthaler, PhD, MS's Profile

David Engelthaler, PhD, MS Related Seminars and Products

Director, Pathogen Genomics

Translational Genomics Research Institute

Dr. David Engelthaler is an Associate Professor and the Director of TGen North, the infectious disease arm of the non-profit Translational Genomics Research Institute. He currently oversees the TGen North Clinical Laboratory, that was stood up in March 2020 to specifically provide COVID-19 testing and has provided tests for over 56,000 Arizonans and has sequenced over 6,000 strains of SARS-CoV-2. Dr. Engelthaler also oversees a number of research groups working on the development of analytical tools to detect and characterize infectious diseases such as tuberculosis, valley fever, MRSA, and others.

His team at TGen also provides genomic services to CDC and local health departments. He has published 135 scientific papers and chapters on epidemiology, disease ecology, genetics, and microbiology and he has two dozen patented inventions, including assays that received either FDA EUA or 510k clearance.

He received his Masters in Microbiology from Colorado State University and his PhD in Biology at Northern Arizona University. He was previously the Arizona State Epidemiologist and a biologist for the CDC.

Dave has worked in federal, state and local government, and has started for-profit and non-profit businesses. Dave sits on a number of local and national Boards and recently he led the establishment of Flagstaff, AZ as “America’s First STEM City”.

Dr. Engelthaler has no disclosures.

Back to Top